Dr. Satya Sanatan Shreenivas, MD

Dr. Shreenivas practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Shreenivas' NPI, 1699830901, was assigned on December 27, 2006. Dr. Shreenivas holds Ohio license 35124124.

Dr. Shreenivas' primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Shreenivas' primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Shreenivas is also affiliated with Cape Cod Hospital. The medical group on file is Cape Cod Healthcare. Dmand AI also links Dr. Shreenivas to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shreenivas practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shreenivas' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Shreenivas' licenses on file in 2 states: Ohio and Pennsylvania.

CMS data shows 139 Medicare services from Dr. Shreenivas across 5 procedure codes in 2024, for 79 Medicare patients. Medicare paid $15,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Shreenivas in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shreenivas' median patient age at 76, with 33% women.

In 2024, Dr. Shreenivas wrote 87 Medicare Part D claims for 16 patients. 97% of them were for generic drugs. CMS names the drug for 50 of them, across 2 drugs with 11 or more claims each, at $410 in total drug cost. In 2021, CMS named 269 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Shreenivas for performance year 2024, reported as part of a group. Dr. Shreenivas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of coronary angioplasty and stenting by Dr. Shreenivas, more than 48% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Shreenivas, published from 2013 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Transcatheter Aortic Valve Replacement, Heart Failure and Prosthesis Design. Dr. Shreenivas has published most often in Catheter Cardiovasc Interv. Dr. Shreenivas' most frequent co-authors are Dean J. Kereiakes, MD, Scott Matthew Lilly, MD and Eugene S. Chung, MD.

Dmand AI links Dr. Shreenivas to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Mitral Valve Insufficiency and Coronary Disease.

CMS Open Payments shows 86 general payments to Dr. Shreenivas from 13 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 82% of the total. Ancora Heart, Inc. paid the most, $46,639.